New FY 2021 RCDC Categories and Funding Data are Now Available
NIH recently updated its Research, Condition, and Disease Classification (RCDC) system with FY 2021 actual spending data and estimates for FY 2022 and 2023. There are now 309 total RCDC publicly reported categories.
The following are new RCDC topics added in FY 2021:
Celiac Disease
Coronaviruses Diagnostics and Prognostics
Coronaviruses Disparities and At-Risk Populations
Coronaviruses Therapeutics and Interventions
Coronaviruses Vaccines
Dissemination and Implementation Research
Lymphatic Research
Lymphedema
Telehealth
Tickborne Diseases
There were also several existing RCDC categories that were renamed, including:
A...
Source: NIH Extramural Nexus - May 23, 2022 Category: Research Authors: NIH Staff Tags: New Resources NIH funding RCDC Source Type: funding
Notice of Correction to Key Dates of RFA-MH-21-230, "Pilot Effectiveness Trials of Interventions for Preschoolers with ADHD (R34 Clinical Trial Required)"
Notice NOT-MH-21-295 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 27, 2021 Category: Research Source Type: funding
Pilot Effectiveness Trials of Interventions for Preschoolers with ADHD (R34 Clinical Trial Required)
Funding Opportunity RFA-MH-21-230 from the NIH Guide for Grants and Contracts. ADHD is a neurodevelopmental disorder with symptoms and impairments that emerge early and persist into adulthood for a substantial portion of affected individuals. While evidence-based treatments exist for school-age children and adolescents with ADHD, findings from longitudinal research suggests that children and adolescents who receive evidence-based interventions for ADHD remain significantly impaired relative to their non-ADHD peers over time. Early identification and intervention for young children with ADHD may be a necessary first step...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 19, 2021 Category: Research Source Type: funding
Refinement and Testing of Interventions to Sustain ADHD Treatment Effects Across Settings and Developmental Transitions (R34 Clinical Trial Required)
Funding Opportunity RFA-MH-20-100 from the NIH Guide for Grants and Contracts. NIMH seeks applications for pilot projects to evaluate the preliminary effectiveness of augmented or modified interventions designed to promote sustained improvement in attention-deficit/hyperactivity disorder (ADHD) symptoms and functional impairments across settings and transitions in children, adolescents, and young adults. An emphasis is placed on trials that go beyond seeking incremental gains in intervention effects, and instead take a theory-driven, empirical approach to applying modifications that will have a significant and enduring ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 4, 2019 Category: Research Source Type: funding
Notice: Refinement and Testing of Interventions to Sustain ADHD Treatment Effects Across Settings and Developmental Transitions
Notice NOT-MH-18-026 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 5, 2018 Category: Research Source Type: funding
National Public Health Practice and Resource Centers for Children with Attention Deficit/Hyperactivity Disorder or Tourette Syndrome
Funding Opportunity Number: CDC-RFA-DD15-150502CONT16 Opportunity Category: ContinuationFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.312Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDCClosing Date: May 02, 2016Award Ceiling: $0Expected Number of Awards: Creation Date: Feb 26, 2016Funding Opportunity Description: National Public Health Practice and Resource Centers for Children with Attention Deficit/Hyperactivity Disorder or Tourette Syndrome (Source: Grants.gov)
Source: Grants.gov - February 27, 2016 Category: Research Tags: Health Source Type: funding
National Public Health Practice and Resource Centers for Children with Attention Deficit/Hyperactivity Disorder or Tourette Syndrome
Funding Opportunity Number: CDC-RFA-DD15-1505 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.312Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: HHS-CDCClosing Date: May 11, 2015Award Ceiling: $900,000Expected Number of Awards: 2Creation Date: Mar 08, 2015Funding Opportunity Description: The purpose of the National Public Health Practice and Resource Centers (NPHPRC) on...
Source: Grants.gov - March 9, 2015 Category: Research Tags: Health Source Type: funding
Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19)
Funding Opportunity Number: RFA-AR-15-014 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.846Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) s...
Source: Grants.gov - March 6, 2015 Category: Research Tags: Health Source Type: funding
Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19)
Funding Opportunity RFA-AR-15-014 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium. The NIAMS, on behalf of the National Institutes of Health, intends to capitalize on recent advances in the science of Patient Reported Outcomes (PROs) to measure the patient experience in clinical care and research in children with a variety of chronic diseases and conditions (e.g., asthma, juvenile arthritis, cystic fibrosis, diabetes, obesity and overweight, chronic kidney disease, inflammato...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 6, 2015 Category: Research Source Type: funding
Klingenstein Third Generation Foundation Fellowship Programs
Fellowship in Child and Adolescent ADHD Fellowship in Child and Adolescent Depression Fellowship in Access to Care Nominations for the fellowship programs are due on January 9, 2015. All applications must be submitted online The Klingenstein Third Generation Foundation awards research grants to post-doctoral investigators at esteemed American medical institutions. At its establishment in 1998, the Foundation funded research fellowships in Child and Adolescent depression. In 2007, the Foundation expanded the Program to include funding for research in Child and Adolescent ADHD. In 2015, KTGF ...
Source: ScanGrants feed - December 4, 2014 Category: Research Authors: Klingenstein Third Generation Foundation Source Type: funding
Pharmacokinetic/Pharmacodynamic (PK/PD) Studies of Methylphenidate Extended Release Products in Attention Deficit Hyperactivity Disorder (ADHD) Patients (U01)
Funding Opportunity Number: RFA-FD-14-015 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthScience and Technology and other Research and DevelopmentCFDA Number: 93.103Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally reco...
Source: Grants.gov - April 29, 2014 Category: Research Tags: Health Science and Technology and other Research and Development Source Type: funding
Pharmacokinetic/Pharmacodynamic (PK/PD) Studies of Methylphenidate Extended Release Products in Attention Deficit Hyperactivity Disorder (ADHD) Patients (U01)
Funding Opportunity RFA-FD-14-015 from the NIH Guide for Grants and Contracts. The purpose of this project is to conduct a prospective PK/PD study in attention deficit hyperactivity disorder (ADHD) patients to link the PK profiles to the time-course of PD activity of methylphenidate extended release products in order to identify additional PK metrics (if any) that may impact the therapeutic equivalence of methylphenidate extended release products. The findings from the PK/PD study will help establish scientific and regulatory standards for assuring therapeutic equivalence of generic methylphenidate extended release p...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 25, 2014 Category: Research Source Type: funding
Call for Applications: CHADD 2014 Young Scientist Research Fund Awards
CHADD is now accepting applications for the 2014 Young Scientist Research Fund Awards. The program recognizes researchers new to the ADHD field who are making contributions to the understanding of ADHD. Through the Fund, CHADD supports researchers with: an unrestricted cash award of $5,000 each recognition at CHADD's Annual International Conference an allowance to cover most conference related expenses (travel, hotel, registration) a one-year CHADD professional membership. Applicants must be in the process of completing a doctoral degree or must have completed such a degree within t...
Source: ScanGrants feed - April 1, 2014 Category: Research Authors: CHADD Source Type: funding
Pharmacometric Modeling and Simulation for Generic Drugs Evaluation
The objectives of this project are to develop quantitative models for generic drugs evaluation in the following areas:
1. Population pharmacokinetic and pharmacodynamic, dose-efficacy, and dose-toxicity modeling and simulation for narrow therapeutic index (NTI) drugs. The goal is to develop models and modeling approaches that will help FDA classify drugs as having a narrow therapeutic index and identify those products that have a clinical use profile that requires tighter control of product quality and equivalence attributes.
2. Pharmacometric modeling and simulation for generic drug substitutability evaluation and pos...
Source: Grants.gov - March 28, 2014 Category: Research Tags: Health Science and Technology and other Research and Development Source Type: funding
Willis-Ekbom Disease Foundation Research Grant Program
The WED Foundation encourages grant applications for basic and clinical research studies of Willis-Ekbom disease. Priority is given to basic science leading to a better understanding of WED/RLS, innovative approaches, interdisciplinary studies and support of promising postdoctoral candidates. Highly ranked research funding priorities include: • Understanding the biological basis of WED/RLS with emphasis on the gene basis • Environmental studies (along the lines of toxic materials and Parkinson’s disease) • Possible MEIS1 mutations that predispose an individual to circadian disrupti...
Source: ScanGrants feed - November 18, 2013 Category: Research Authors: Willis-Ekbom Disease Foundation Source Type: funding
